ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea
· Delayed Price · Currency is KRW 1,426.00
-243.00 (-14.56%)
At close: Mar 21, 2025, 3:30 PM KST
ADBiotech Revenue
In the year 2024, ADBiotech had annual revenue of 11.14B KRW with 6.34% growth. ADBiotech had revenue of 4.64B in the quarter ending December 31, 2024, with 101.57% growth.
Revenue
11.14B
Revenue Growth
+6.34%
P/S Ratio
1.25
Revenue / Employee
n/a
Employees
59
Market Cap
13.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.14B | 664.30M | 6.34% |
| Dec 31, 2023 | 10.47B | -159.63M | -1.50% |
| Dec 31, 2022 | 10.63B | -1.21B | -10.21% |
| Dec 31, 2021 | 11.84B | 2.02B | 20.63% |
| Dec 31, 2020 | 9.82B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |